AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,644,000 | +4716.3% | 300 | -90.9% | 0.06% | +6200.0% |
| Q1 2019 | $221,000 | -22.5% | 3,291 | -11.2% | 0.00% | 0.0% |
| Q3 2018 | $285,000 | -9.5% | 3,706 | -0.8% | 0.00% | -50.0% |
| Q2 2018 | $315,000 | +7.5% | 3,737 | +4.7% | 0.00% | 0.0% |
| Q1 2018 | $293,000 | +5.8% | 3,570 | -47.4% | 0.00% | 0.0% |
| Q1 2016 | $277,000 | -37.3% | 6,793 | -0.4% | 0.00% | -33.3% |
| Q4 2015 | $442,000 | -20.2% | 6,818 | -13.0% | 0.00% | -25.0% |
| Q3 2015 | $554,000 | -7.2% | 7,833 | +45.6% | 0.00% | 0.0% |
| Q2 2015 | $597,000 | -7.2% | 5,379 | -30.1% | 0.00% | 0.0% |
| Q1 2015 | $643,000 | -3.2% | 7,699 | +14.1% | 0.00% | 0.0% |
| Q4 2014 | $664,000 | +110.8% | 6,750 | +31.6% | 0.00% | +100.0% |
| Q3 2014 | $315,000 | – | 5,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |